SilverArc Capital
- Company typePrivate
- Founded-
- HeadquartersBoston, United States
- Headcount—
- GTM typeB2B
- OfferingServices
SilverArc Capital firmographics
Firmographics- Name
- SilverArc Capital
- Legal name
- SilverArc Capital Management, LLC and SilverArc Capital, LLC
- Website
- https://silverarccapital.com
- Company type
- Private
- Operating status
- Operating
- Ownership category
- akta.pro rank
SilverArc Capital industry classification
Industry- Product category
- Healthcare Investment Management
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Private Equity Fundraising Placement (FSAEALAB)
- akta.pro secondary industries
- Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE), Institutional Capital Introduction (LP/Family Office/Endowment Matching) (FSAEALAI)
Keywords
Where SilverArc Capital is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SilverArc Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
SilverArc Capital product offering
Product offeringCore offering
SilverArc Capital is an investment management firm that manages investment funds focused exclusively on the healthcare sector. The firm provides capital to clinical-stage biopharmaceutical and life sciences companies and manages these funds on behalf of qualified investors, including Professional Investors, High Net Worth individuals, Eligible Counterparties, and SilverArc employees.
Product overview
SilverArc Capital is a healthcare-focused investment management firm. Based on the source material, the company manages investment funds for accredited investors and provides access through a client portal with login and registration functionality. No distinct software products, platforms, or named service offerings were identified in the provided sources.
Differentiator
Problem solved
Functional benefit
Products and services
- Healthcare-Focused Investment Funds
- Investor Client Portal
Companies that use SilverArc Capital
Customer profileIdeal customer profiles2 records
SilverArc Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SilverArc Capital partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights4 records
SilverArc Capital competitors and assessment
Company assessmentDirect peers
- venBio: Life sciences venture capital firm investing in biopharma across development stages with a healthcare-exclusive mandate. Directly comparable to SilverArc as a sector-specialist with clinical-stage orientation.
- Pontifax: Healthcare-dedicated venture capital firm investing globally in therapeutics and medtech. Comparable as a sector-specialist investor with similar clinical-stage investment profile.
- RA Capital Management: Healthcare-focused crossover and venture investor that frequently leads and participates in clinical-stage biopharma financings, including the Corxel Series D1 round in which SilverArc co-invested. Directly comparable as a healthcare-dedicated fund manager participating in similar deal types and stages.
- OrbiMed: One of the largest dedicated healthcare investment firms globally, deploying capital across stages, geographies, and modalities in biopharma, medtech, and diagnostics. Directly comparable to SilverArc as a healthcare-exclusive investment manager with a multi-stage mandate.
- Atlas Venture: Early-stage life sciences venture firm that builds biotechnology companies from inception through clinical development. Comparable in life sciences specialization and stage mix, particularly to SilverArc's seed-stage activity (e.g., Modulight).
- Perceptive Advisors: Healthcare-focused investment manager combining credit and equity strategies, frequently participating in biopharma financings. Comparable to SilverArc in healthcare specialization and crossover/follow-on participation profile.
- 5AM Ventures: Early-stage life sciences venture firm focused on founding and developing biopharma companies. Comparable in life sciences specialization and clinical-stage investment focus.
- Deerfield Management: Healthcare-dedicated investment firm providing capital and operational support to biopharma and medical technology companies across stages. Comparable as a sector-specialist manager with similar clinical-stage orientation.
- Cormorant Asset Management: Healthcare-focused crossover investor that participates in biopharma financings alongside specialist VCs and hedge funds. Directly comparable in deal profile, stage focus, and co-investment behavior with SilverArc's disclosed activity.
Broad incumbents
- Janus Henderson Investors: Large global asset manager with dedicated healthcare equity capability across public and private markets, and a co-investor alongside SilverArc in the Cellectar financing. Comparable as an incumbent healthcare capital provider operating at materially larger scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
SilverArc Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
SilverArc Capital leadership team
Management profileNumber of profiles
Profiles1 record
SilverArc Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SilverArc Capital M&A and investment
M&A and investmentM&A
Investments18 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SilverArc Capital
What does SilverArc Capital do?
SilverArc Capital is an investment management firm that manages investment funds focused exclusively on the healthcare sector. The firm provides capital to clinical-stage biopharmaceutical and life sciences companies and manages these funds on behalf of qualified investors, including Professional Investors, High Net Worth individuals, Eligible Counterparties, and SilverArc employees.
Is SilverArc Capital a public or private company?
SilverArc Capital is a private company. It is classified as unknown and is currently operating.
When was SilverArc Capital founded?
SilverArc Capital was founded in -1.
Where is SilverArc Capital based?
SilverArc Capital is headquartered in Boston, United States, in the North America region.
Who are SilverArc Capital's main competitors?
Direct peers on record are venBio, Pontifax, RA Capital Management, OrbiMed, Atlas Venture, Perceptive Advisors, 5AM Ventures, Deerfield Management and Cormorant Asset Management. Janus Henderson Investors is listed as a broad incumbent.
Does SilverArc Capital have an API?
No public API is recorded for SilverArc Capital.
What industry is SilverArc Capital in?
SilverArc Capital's product category is Healthcare Investment Management. Its primary akta.pro industry code is FSAEALAB, Private Equity Fundraising Placement, with a secondary code of BPAHAOAE, Equity Capital Advisory (Private Equity Placements, Growth Capital). Its NAICS code is 523940 and its SIC code is 6282.